Korábbi/eredmények

This page provides the list of testing proposal consultations for which the deadline for comments has passed. ECHA addresses all third-party contributions in the dossier evaluation decisions addressed to the registrant.

Further instructions

To see if testing proposals submitted by registrants, and for which ECHA has held a third-party consultation, were subsequently withdrawn, please consult the table below. First, follow the link to the related aggregated registration dossier (if it is already published). There you can review the details of the testing proposed and other information on the substance that is subject to the testing proposal. The admissibility of any testing proposal will be concluded only after the third party consultation. Later during the testing proposal examination process, you may check the same section in the disseminated dossier to see if a testing proposal previously present has been withdrawn. The reasons for withdrawal may be that the registrant has reviewed their assessment or has taken into account the third-party comments provided to ECHA and communicated to them.

2 011 eredményből 1 951 - 2 000 megmutatása.

Name	EC Number	CAS Number	Hazard endpoint for which vertebrate testing was proposed	Date of publication to call for available information	Deadline for submitting information
l-Glutamic acid, N-coco acyl derivs., disodium salts	269-085-1	68187-30-4	Sub-chronic toxicity (90-day): oral	22/09/2022	07/11/2022	Details
methyl-1h-benzotriazole	249-596-6	29385-43-1	Sub-chronic toxicity (90-day): oral	16/12/2020	01/02/2021	Details
N,N-bis(2-ethylhexyl)-5-methyl-1H-benzotriazole-1-methylamine, N,N-bis(2-ethylhexyl)-4-methyl-1H-benzotriazole-1-methylamine, 2H-Benzotriazole-2-methanamine, N,N-bis(2-ethylhexyl)-4-methyl-, 2H-Benzotriazole-2-methanamine, N,N-bis(2-ethylhexyl)-5-methyl-, 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-6-methyl-(Mixture)	939-700-4	-	Sub-chronic toxicity (90-day): oral	21/10/2019	05/12/2019	Details
N-[(3-methyl-1H-pyrazol-1-yl)methyl]acetamide; N-[(5-methyl-1H-pyrazol-1-yl)methyl]acetamide	700-208-8	-	Sub-chronic toxicity (90-day): oral	04/10/2018	19/11/2018	Details
O,O,O-triphenyl phosphorothioate	209-909-9	597-82-0	Sub-chronic toxicity (90-day): oral	16/12/2016	30/01/2017	Details
Octadecylamine, reaction products with 4,4'-methylenediphenyl diisocyanate	928-226-3	-	Sub-chronic toxicity (90-day): oral	16/10/2014	01/12/2014	Details
Octylphosphonic acid	225-218-5	4724-48-5	Sub-chronic toxicity (90-day): oral	03/04/2023	22/05/2023	Details
Pentane-1,2-diol	226-285-3	5343-92-0	Sub-chronic toxicity (90-day): oral	16/06/2011	01/08/2011	Details
pentasodium 5-{[4-chloro-6-({4-[2-(sulfooxy)ethanesulfonyl]phenyl}amino)-1,3,5-triazin-2-yl]amino}-3-[2-(1,5-disulfonaphthalen-2-yl)diazen-1-yl]-4-hydroxynaphthalene-2,7-disulfonate	402-420-3	89157-03-9	Sub-chronic toxicity (90-day): oral	25/06/2019	09/08/2019	Details
Phosphonium, tetrakis(hydroxymethyl)-, chloride (1:1), reaction products with 1-tetradecanamine and urea	436-230-7	359406-89-6	Sub-chronic toxicity (90-day): oral	06/03/2012	20/04/2012	Details
Poly[oxy(methyl-1,2-ethanediyl)], α,α'-(2,2-dimethyl-1,3-propanediyl)bis[ω-hydroxy-]	610-848-9	52479-58-0	Sub-chronic toxicity (90-day): oral	18/09/2014	03/11/2014	Details
Polysulfides, bis[3-(triethoxysilyl)propyl]	915-673-4	-	Sub-chronic toxicity (90-day): oral	21/10/2021	07/12/2021	Details
Polysulfides, di-tert-nonyl	270-336-2	68425-16-1	Sub-chronic toxicity (90-day): oral	06/09/2018	22/10/2018	Details
Reaction mass of 1-(C12-18-(even numbered))-alkyl-tetrahydropyrimidin-2(1H)-imine acetate salt and 1-(3-((C12-18-(even numbered))-alkyl-amino)propyl)guanidine acetate salt and 1-(C12-18-(even numbered))-alkyl-1-(3-guanidinopropyl)guanidine acetate salt	939-650-3	-	Sub-chronic toxicity (90-day): oral	10/05/2022	27/06/2022	Details
Reaction mass of 2,2'-[(4-methylphenyl)imino]bisethanol and Ethanol 2-[[2-(2-hydroxyethoxy)ethyl](4-methylphenyl)amino]-	911-490-9	-	Sub-chronic toxicity (90-day): oral	27/05/2019	11/07/2019	Details
Reaction mass of 2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4-[2-[4-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-2-sulfophenyl]ethenyl]-3-sulfophenyl]azo]-4-hydroxy-, compd. with 2,2',2''-nitrilotris[ethanol] (1:5) and 3,3'-[ethylenebis[(3-sulpho-p-phenylene)azo]]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, compound with 2,2',2''-nitrilotriethanol (1:6) and 3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[6-amino-4-hydroxynaphthalene-2-sulphonic] acid, compound with 2,2',2''-nitrilotriethanol (1:4)	916-899-6	-	Sub-chronic toxicity (90-day): oral	10/08/2018	24/09/2018	Details
Reaction mass of 3-isopropyl-6-methylenecyclohexene and (4R)-1-methyl-4-(prop-1-en-2-yl)cyclohexene and (4S)-1-methyl-4-(prop-1-en-2-yl)cyclohexene	939-009-8	-	Sub-chronic toxicity (90-day): oral	21/12/2021	04/02/2022	Details
Reaction mass of Amines, coco alkyl and β-Alanine, N-(2-carboxyethyl)-, N-coco alkyl derivs. and β-Alanine, N-coco alkyl derivs.	915-790-0	-	Sub-chronic toxicity (90-day): oral	12/12/2014	26/01/2015	Details
Reaction mass of Benzeneacetic acid, alpha-oxo-, 1,1'-(oxydi-2,1-ethanediyl) ester and Benzeneacetic acid, alpha-oxo-, 2-(2-hydroxyethoxy)ethyl ester	442-300-8	-	Sub-chronic toxicity (90-day): oral	04/10/2013	18/11/2013	Details
Reaction mass of butane-2,2-diyl dihydroperoxide and di-sec-butylhexaoxidane	700-954-4	1338-23-4	Sub-chronic toxicity (90-day): oral	19/12/2013	03/02/2014	Details
Reaction mass of sodium 1-methoxy-1-oxohexadecane-2-sulphonate and sodium methyl 2-sulphooctadecanoate	911-616-2	-	Sub-chronic toxicity (90-day): oral	25/05/2020	09/07/2020	Details
Reaction mass of trisodium [μ-[4-[[3,3'-dihydroxy-4'-[(2-hydroxy-6-sulpho-1-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]-3-hydroxynaphthalene-2,7-disulphonato(7-)]]dicuprate(3-) and triammonium [μ-[4-[[3,3'-dihydroxy-4'-[(2-hydroxy-6-sulpho-1-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]-3-hydroxynaphthalene-2,7-disulphonato(7-)]]dicuprate(3-)	945-577-8	-	Sub-chronic toxicity (90-day): oral	01/07/2021	16/08/2021	Details
Reaction products of tryglycerides, C8-C18 (even numbered) and C18-unsaturated, glycerine and ethylene oxide	939-459-5	-	Sub-chronic toxicity (90-day): oral	30/11/2015	14/01/2016	Details
Silver	231-131-3	7440-22-4	Sub-chronic toxicity (90-day): oral	29/04/2011	14/06/2011	Details
Silver nitrate	231-853-9	7761-88-8	Sub-chronic toxicity (90-day): oral	16/06/2011	01/08/2011	Details
Sodium dihydrogenorthophosphate	231-449-2	7558-80-7	Sub-chronic toxicity (90-day): oral	24/07/2019	09/09/2019	Details
Sodium p-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]benzenesulphonate	223-989-2	4156-21-2	Sub-chronic toxicity (90-day): oral	29/04/2014	13/06/2014	Details
Tar, brown-coal, low-temp.	309-886-6	101316-84-1	Sub-chronic toxicity (90-day): oral	29/07/2011	12/09/2011	Details
tellurium dioxide	231-193-1	7446-07-3	Sub-chronic toxicity (90-day): oral	16/03/2015	30/04/2015	Details
Tetrakis(hydroxymethyl)phosphonium chloride, oligomeric reaction products with urea	500-057-6	27104-30-9	Sub-chronic toxicity (90-day): oral	02/09/2011	17/10/2011	Details
Tetramethylammonium chloride	200-880-8	75-57-0	Sub-chronic toxicity (90-day): oral	29/04/2014	13/06/2014	Details
triethoxy(methyl)silane	217-983-9	2031-67-6	Sub-chronic toxicity (90-day): oral	25/05/2020	09/07/2020	Details
Triisotridecyl phosphite	278-758-9	77745-66-5	Sub-chronic toxicity (90-day): oral	25/06/2019	09/08/2019	Details
Vinyl ethylene carbonate	700-261-7	4427-96-7	Sub-chronic toxicity (90-day): oral	30/06/2023	14/08/2023	Details
Vinyl laurate	218-414-7	2146-71-6	Sub-chronic toxicity (90-day): oral	16/05/2011	30/06/2011	Details
Sodium 4(or 5)-methyl-1H-benzotriazolide	265-004-9	64665-57-2	Sub-chronic toxicity (90-day): oral \|\| Note: testing proposed with Tolyltriazole (EC 249-596-6)	16/12/2020	01/02/2021	Details
Reaction products of 1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-(C11-17 and C17 unsatd. alkyl) derivs. and sodium hydroxide and 2-propenoic acid	946-533-0	-	Sub-chronic toxicity (90-day): oral \|\| Note: testing proposed with β-Alanine, N-(2-aminoethyl)-N-(2-hydroxyethyl)-, N-coco acyl derivs., monosodium salts (EC 298-632-7)	16/12/2020	01/02/2021	Details
trimethoxy(2,4,4-trimethylpentyl)silane	251-995-5	34396-03-7	Sub-chronic toxicity (90-day): oral Note: testing proposed with triethoxy(2,4,4-trimethylpentyl)silane (EC 252-558-1, CAS 35435-21-3) "	25/06/2015	10/08/2015	Details
Amines, C12-14-tert-alkyl, mixed sec-Bu and iso-Bu phosphates	306-227-4	96690-34-5	Sub-chronic toxicity (90-day): oral \|\| Note: testing proposed with Amines, C11-14-branched alkyl, monohexyl and dihexyl phosphates (EC 279-632-6) \|\| Note: Testing proposal is based on concern identified by the registrant.	23/11/2020	07/01/2021	Details
Resin acids and Rosin acids, reaction products with formaldehyde, potassium salt	295-855-1	92129-53-8	Sub-chronic toxicity (90-day): oral //Note: Testing proposed with Rosin (CAS RN 8050-09-7), Rosin, hydrogenated (CAS RN 65997-06-0), and Rosin, reaction products with formaldehyde (CAS RN 91081-53-7)	02/07/2013	16/08/2013	Details
Rosin, oligomers	500-163-2	65997-05-9	Sub-chronic toxicity (90-day): oral //Note: Testing proposed with Rosin (CAS RN 8050-09-7), Rosin, hydrogenated (CAS RN 65997-06-0), and Rosin, reaction products with formaldehyde (CAS RN 91081-53-7)	02/07/2013	16/08/2013	Details
Resin acids and Rosin acids, esters with ethylene glycol	270-986-7	68512-65-2	Sub-chronic toxicity (90-day): oral //Note: Testing proposed with Rosin, ethylene glycol ester (CAS RN 68512-65-2)	02/07/2013	16/08/2013	Details
Resin acids and Rosin acids, hydrogenated, Me esters	232-476-2	8050-15-5	Sub-chronic toxicity (90-day): oral //Note: Testing proposed with Rosin, methyl ester (CAS RN 68186-14-1), Rosin, ethylene glycol ester (CAS RN 68512-65-2) and Rosin, triethylene glycol ester (CAS RN 8050-25-7)	02/07/2013	16/08/2013	Details
N,N''-propane-1,3-diylbis[N'-octadecylurea	252-667-4	35674-65-8	Sub-chronic toxicity (90-day): oral Reproductive toxicity (pre-natal developmental toxicity)	29/03/2016	13/05/2016	Details
branched-nonyl 3,5,5 trimethylhexanoate	701-133-3	-	Sub-chronic toxicity (90-day): oral \|\| Note: previous EC no 609-993-0	21/05/2018	05/07/2018	Details
2-Propyn-1-ol, reaction product with 1-2.5 moles of oxirane	941-793-1	-	Sub-chronic toxicity (90-day): oral \|\| Note: testing proposed with 2-Propyn-1-ol, compd. with methyloxirane (EC 609-530-2, CAS 38172-91-7)	17/04/2015	04/06/2015	Details
tetraethylammonium hydroxide	201-073-3	77-98-5	Sub-chronic toxicity (90-day): oral \|\| Note: testing proposed with N,N,N-trimethylmethanaminium chloride (EC 200-880-8; CAS 75-57-0)	30/09/2015	16/11/2015	Details
Reaction mass of 4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane and 4,4,14,14-tetraethoxy-3,15-dioxa-8,9,10-trithia-4,14-disilaheptadecane	915-748-1	-	Sub-chronic toxicity (90-day): oral \|\| Note: testing proposed with polysulfides, bis[3-(triethyoxysilyl)propyl (CAS No 211519-85-6)	25/05/2020	09/07/2020	Details
trimethoxyoctylsilane	221-338-7	3069-40-7	Sub-chronic toxicity (90-day): oral \|\| Note: testing proposed with triethoxy(2,4,4-trimethylpentyl)silane (CAS 35435-21-3)	07/08/2015	22/09/2015	Details
octyltrichlorosilane	226-112-1	5283-66-9	Sub-chronic toxicity (90-day): oral \|\| Note: testing proposed with triethoxy(2,4,4-trimethylpentyl)silane (EC 252-558-1, CAS 35435-21-3)	25/06/2015	10/08/2015	Details

2 011 eredményből 1 951 - 2 000 megmutatása.

Export in: